Publication | Closed Access

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

InflammationCell TherapyTransplantationAutoimmune DiseasePhase I/ii Double-blindStem Cell TransplantationImmunologyAutoimmunityPlacebo-controlled StudyGraft RejectionImmunosuppressionImmunotherapyMedicineCell TransplantationAcute Gvhd Prevention